Lucid Diagnostics Inc. (LUCD)

Turnstone Biologics Revenue

Lucid Diagnostics had revenue of $1.16M in the quarter ending June 30, 2025, with 19.16% growth. This brings the company's revenue in the last twelve months to $4.36M, up 14.74% year-over-year. In the year 2024, Lucid Diagnostics had annual revenue of $4.35M with 79.00% growth.

• Revenue (ttm): $4.36M
• Revenue Growth: +14.74%
• P/S Ratio: 15.57
• Revenue / Employee: $60,556
• Employees: 72
• Market Cap: 100.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.35M	1.92M	79.00%
Dec 31, 2023	2.43M	2.05M	544.03%
Dec 31, 2022	377.00K	-123.00K	-24.60%
Dec 31, 2021	500.00K	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.